CD1C and neoplasm: To assess whether DCs and monocytes can give rise to tumor-induced CD1c+CD14+, we started in vitro differentiation assays with CD14− cDC2s or CD14+ monocytes isolated from HD PBMCs (purity ≥ 95%, Figure S3B).